Universidade Federal de Santa Catarina UFSC, Departmento de Patologia Delfino Conti St. Trindade Post code: 88040-370. Florianópolis, SC, Brazil
Med Oral Patol Oral Cir Bucal. 2024 Mar 1;29(2):e273-e279. doi: 10.4317/medoral.26248.
The differentiation between primary and metastatic salivary gland neoplasms (SGNs) helps in determining appropriate management strategies, including the need for additional diagnostic tests, surveillance, or aggressive treatment. The purpose of this study was to identify and quantify the immature and mature dendritic cells (DCs) in metastatic and no metastatic SGNs and determine its association with clinicopathological findings.
Cross-sectional, observational, and descriptive study that includes 33 malignant salivary gland neoplasms [MSGN (6, 18.1% metastatic)], and 22 pleomorphic adenomas (PA), as a control group. Clinical and histopathological characteristics were obtained. Immunohistochemistry for human leukocyte antigen D-related (HLA-DR), CD1a, CD83, and Ki-67 proteins was done. Positive intra- and peritumoral DCs were counted.
Individuals with MSGN had a lower density of intratumoral HLA-DR+ cells than those with PA (p=0.001), Ki-67 immunostaining was significantly higher in MSGN than in PA (6% vs. 1.4%, p<0.001). Metastatic MSGN showed less intratumoral CD1a+ than non-metastatic (3.2 vs. 165.1, p=0.001). No differences in intra- and peritumoral CD83+ cells were found between benign and malignant SGN.
These results suggest that the immune-protective function of intratumoral DCs is compromised in MSGNs. DCs markers may represent useful prediction tools for metastases in salivary gland malignancies, with crucial implications in the implementation of appropriate disease management strategies.
原发性和转移性涎腺癌(SGN)的鉴别有助于确定适当的管理策略,包括是否需要额外的诊断测试、监测或积极治疗。本研究的目的是识别和量化转移性和非转移性 SGN 中的未成熟和成熟树突状细胞(DC),并确定其与临床病理发现的关系。
这是一项横断面、观察性和描述性研究,包括 33 例恶性涎腺癌(MSGN[6 例,18.1%转移性])和 22 例多形性腺瘤(PA)作为对照组。获取临床和组织病理学特征。进行人类白细胞抗原 D 相关(HLA-DR)、CD1a、CD83 和 Ki-67 蛋白的免疫组织化学染色。计算阳性的肿瘤内和肿瘤周围 DC 数量。
MSGN 患者肿瘤内 HLA-DR+细胞密度低于 PA 患者(p=0.001),MSGN 患者的 Ki-67 免疫染色明显高于 PA 患者(6%比 1.4%,p<0.001)。转移性 MSGN 肿瘤内 CD1a+细胞数明显低于非转移性 MSGN(3.2 比 165.1,p=0.001)。良性和恶性 SGN 之间肿瘤内和肿瘤周围 CD83+细胞无差异。
这些结果表明,MSGN 肿瘤内 DC 的免疫保护功能受损。DC 标志物可能成为涎腺癌转移的有用预测工具,对实施适当的疾病管理策略具有重要意义。